J&J, Bayer lose first Xarelto bleeding case, hit with $28M verdictadmin 5th December 2017 Uncategorised 0
After three wins in cases over the risks of blockbuster blood thinner Xarelto, Bayer and Johnson & Johnson have encountered their first defeat. A jury in Philidelphia ordered the companies to pay $28 million to plaintiff Lynn Hartman. The companies plan to appeal.
More: J&J, Bayer lose first Xarelto bleeding case, hit with M verdict